Of the 750 genes in the nCounter® PanCancer IO360 gene expression panel, CCL19 and CCL21 showed the highest differential expression between primary BC and BCBM (5.82- and 4.72-fold change, respectively; adjusted p < 0.001, both) (Figure 1c). Here, CCL19 is linked to breast cancer.